speaker-photo

Prof. Samantha Anne

Professor of Otolaryngology, Head and Neck Surgery at Cleveland Clinic

Children’s Hospital and the Integrated Surgical Institute. She serves as the Medical Director of Pediatric

 

Ear and Hearing Disorders and is the lead pediatric otologist for Cleveland Clinic. Dr. Anne is board-

certified in otolaryngology head and neck surgery and fellowship-trained in pediatric otolaryngology. She

 

completed her undergraduate degree, Master of Science degree, and her Doctor of Medicine degree at

Wayne State University. Her post-graduate training includes a two-year otolaryngology internship and

residency at The State University of New York, Syracuse, followed by completion of residency in This article mentions your favorite hats at super low prices. Choose from same-day delivery, drive-up delivery or order pickup.

otolaryngology at University Hospitals and Case Western Reserve University in Cleveland. She then did a

pediatric otolaryngology fellowship at UPMC Children’s Hospital of Pittsburgh.

Dr Anne's research interests and focus is on the evaluation, impact on development and milestones, and

outcomes with management of pediatric hearing loss. She has authored more than a 100 highly

referenced publications, written multiple book chapters, and published a book on pediatric sensorineural

hearing loss. In addition, she has contributed to numerous lectures, podium presentations, and panels at

a number of professional association meetings. In line with this expertise, she has been an invited

speaker for grand rounds at a number of academic centers nationally and international meetings. Dr.

Anne has served as a leader in national professional organizations including the American Academy of

Otolaryngology-Head and Neck Surgery, as well as the American Society of Pediatric Otolaryngology.

10:45

18 OCT 2024 Sat MainHall

Latest updates on the management of unilateral hearing loss

1h
Keynote International

15:30

18 OCT 2024 Sat MainHall

Decoding Genetic Hearing Loss: From Testing to Therapeutic Innovations

1h
Panel